Todd Berard Sells 3,000 Shares of BioLife Solutions Inc (BLFS) Stock

BioLife Solutions Inc (NASDAQ:BLFS) VP Todd Berard sold 3,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $16.67, for a total transaction of $50,010.00. Following the transaction, the vice president now owns 44,074 shares in the company, valued at $734,713.58. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Todd Berard also recently made the following trade(s):

  • On Thursday, February 14th, Todd Berard sold 3,000 shares of BioLife Solutions stock. The stock was sold at an average price of $16.07, for a total transaction of $48,210.00.
  • On Tuesday, January 15th, Todd Berard sold 3,000 shares of BioLife Solutions stock. The stock was sold at an average price of $12.12, for a total transaction of $36,360.00.

NASDAQ BLFS traded up $1.01 during mid-day trading on Friday, hitting $18.70. The company’s stock had a trading volume of 412,503 shares, compared to its average volume of 160,510. BioLife Solutions Inc has a 52-week low of $4.85 and a 52-week high of $26.35. The firm has a market capitalization of $327.27 million, a price-to-earnings ratio of -89.05 and a beta of 1.65.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings results on Thursday, March 14th. The medical equipment provider reported $0.04 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.04. BioLife Solutions had a net margin of 10.42% and a return on equity of 8.63%. The firm had revenue of $5.46 million for the quarter, compared to analyst estimates of $5.47 million. As a group, sell-side analysts anticipate that BioLife Solutions Inc will post 0.16 earnings per share for the current fiscal year.

BLFS has been the topic of several research reports. BidaskClub lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating in a report on Saturday, March 9th. ValuEngine upgraded shares of BioLife Solutions from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 28th. Zacks Investment Research lowered shares of BioLife Solutions from a “buy” rating to a “hold” rating in a report on Tuesday, March 12th. Finally, Janney Montgomery Scott upgraded shares of BioLife Solutions to a “buy” rating and set a $5.00 price target on the stock in a report on Thursday, December 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $17.75.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Canton Hathaway LLC purchased a new position in BioLife Solutions in the fourth quarter valued at approximately $66,000. GSA Capital Partners LLP purchased a new stake in shares of BioLife Solutions during the third quarter valued at approximately $200,000. Northern Trust Corp raised its stake in shares of BioLife Solutions by 24.4% during the second quarter. Northern Trust Corp now owns 16,304 shares of the medical equipment provider’s stock valued at $186,000 after purchasing an additional 3,200 shares during the period. Monashee Investment Management LLC purchased a new stake in shares of BioLife Solutions during the third quarter valued at approximately $337,000. Finally, Bank of Montreal Can raised its stake in shares of BioLife Solutions by 91.6% during the third quarter. Bank of Montreal Can now owns 19,286 shares of the medical equipment provider’s stock valued at $338,000 after purchasing an additional 9,222 shares during the period. Hedge funds and other institutional investors own 40.67% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Todd Berard Sells 3,000 Shares of BioLife Solutions Inc (BLFS) Stock” was originally posted by PressOracle and is the sole property of of PressOracle. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://pressoracle.com/news/2019/03/17/todd-berard-sells-3000-shares-of-biolife-solutions-inc-blfs-stock-2.html.

About BioLife Solutions

BioLife Solutions, Inc develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death.

Further Reading: What is the Gross Domestic Product (GDP)?

Insider Buying and Selling by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.